PARNASSUS INVESTMENTS, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 948669
San Francisco, CA
Position in REGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$59,471,998
-$15,856,538 QoQ
Shares Held
95,378
-2.2% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#112
of 1,322 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PARNASSUS INVESTMENTS, LLC holds $91,193,382 across 3 Biotechnology names. REGN ranks #1 (65.2% of the industry book) .
All Filings in REGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,471,998 | 95,378 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $75,328,536 | 97,495 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $74,520,189 | 96,545 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $56,802,202 | 101,023 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $53,069,100 | 101,084 | Shares | Sole | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||